Malaria control in central Malaita, Solomon Islands 2. Local perceptions of the disease and practices for its treatment and prevention.
Government health policy for malaria control in Solomon Islands has three main objectives: (1) early diagnosis and treatment of malaria at a health service; (2) reduction of human-vector contact through widespread use of insecticide-impregnated bed nets; and (3) provision of malaria chemoprophylaxis for pregnant women. Social research was carried out in thirteen villages in central Malaita to determine local attitudes toward malaria and to estimate the level of participation in malaria control activities. Interviews with 124 care-givers who had children 0-10 years of age, 20 focus group discussions and four evening structured observations were research methods used. Antimalarial drugs were the most favoured treatment, and use of traditional medicines and healers were reportedly minimal. Twenty-five percent of respondents reported keeping chloroquine at home and 42% said they would use chloroquine before seeking diagnosis and treatment from a health service. Structured observations suggest that protection against mosquitoes is poor during the evening. Fifty-two percent of respondents reported using fire and 32% said they used bed nets to protect themselves from mosquitoes. Participants had contradictory beliefs on the threat of malaria during pregnancy and the safety of taking chloroquine prophylaxis. Implications of malaria treatment and prevention practices are discussed, and recommendations for improving malaria control are presented.
Dulhunty
J M
JM
Tropical Health Program, University of Queensland Medical School, Herston Road, Herston, Australia. s364738@student.uq.edu.au
Yohannes
K
K
Kourleoutov
C
C
Manuopangai
V T
VT
Polyn
M K
MK
Parks
W J
WJ
Bryan
J H
JH
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D001294:Attitude to Health; D017028:Caregivers; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine / Q000627:therapeutic use; D009033:Culicidae / Q000187:drug effects; D005260:Female; D006291:Health Policy; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D007303:Insect Vectors / Q000187:drug effects; D008288:Malaria / Q000453:epidemiology / Q000469:parasitology / Q000517:prevention & control*; D008297:Male; D008519:Medicine, Traditional; D008542:Melanesia; D010290:Parents; D010963:Plasmodium falciparum; D010966:Plasmodium vivax; D011247:Pregnancy; D011482:Protective Devices; D012424:Rural Population; D011795:Surveys and Questionnaires
D000962:Antimalarials; D002738:Chloroquine